nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—ALB—acquired immunodeficiency syndrome	0.583	1	CbGaD
Fospropofol—ALB—Saquinavir—acquired immunodeficiency syndrome	0.043	0.51	CbGbCtD
Fospropofol—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0412	0.489	CbGbCtD
Fospropofol—Hypoxemia—Zidovudine—acquired immunodeficiency syndrome	0.018	0.0742	CcSEcCtD
Fospropofol—Hypoxemia—Lamivudine—acquired immunodeficiency syndrome	0.0129	0.053	CcSEcCtD
Fospropofol—ALPL—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.00679	1	CbGdCrCtD
Fospropofol—Tingling sensation—Didanosine—acquired immunodeficiency syndrome	0.00597	0.0246	CcSEcCtD
Fospropofol—Hypoxia—Zidovudine—acquired immunodeficiency syndrome	0.0057	0.0235	CcSEcCtD
Fospropofol—Tingling sensation—Stavudine—acquired immunodeficiency syndrome	0.00518	0.0213	CcSEcCtD
Fospropofol—Hypoxia—Ritonavir—acquired immunodeficiency syndrome	0.00443	0.0182	CcSEcCtD
Fospropofol—ALPL—blood—acquired immunodeficiency syndrome	0.0042	0.0531	CbGeAlD
Fospropofol—Hypoxia—Lamivudine—acquired immunodeficiency syndrome	0.00407	0.0167	CcSEcCtD
Fospropofol—Hepatic failure—Didanosine—acquired immunodeficiency syndrome	0.00387	0.016	CcSEcCtD
Fospropofol—Tingling sensation—Delavirdine—acquired immunodeficiency syndrome	0.00378	0.0156	CcSEcCtD
Fospropofol—Apnoea—Efavirenz—acquired immunodeficiency syndrome	0.00375	0.0154	CcSEcCtD
Fospropofol—ALPL—lung—acquired immunodeficiency syndrome	0.00368	0.0466	CbGeAlD
Fospropofol—Propofol—ALB—acquired immunodeficiency syndrome	0.00361	1	CrCbGaD
Fospropofol—Hepatic failure—Nevirapine—acquired immunodeficiency syndrome	0.00348	0.0143	CcSEcCtD
Fospropofol—Hepatic failure—Stavudine—acquired immunodeficiency syndrome	0.00336	0.0138	CcSEcCtD
Fospropofol—Hepatic failure—Abacavir—acquired immunodeficiency syndrome	0.00331	0.0136	CcSEcCtD
Fospropofol—Hepatic failure—Indinavir—acquired immunodeficiency syndrome	0.00272	0.0112	CcSEcCtD
Fospropofol—ALPL—brain—acquired immunodeficiency syndrome	0.00261	0.033	CbGeAlD
Fospropofol—Hepatic failure—Efavirenz—acquired immunodeficiency syndrome	0.00257	0.0106	CcSEcCtD
Fospropofol—ALPL—lymph node—acquired immunodeficiency syndrome	0.00252	0.0318	CbGeAlD
Fospropofol—Hepatic failure—Delavirdine—acquired immunodeficiency syndrome	0.00246	0.0101	CcSEcCtD
Fospropofol—GABRG3—nervous system—acquired immunodeficiency syndrome	0.00202	0.0255	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.00194	0.00801	CcSEcCtD
Fospropofol—GABRG3—central nervous system—acquired immunodeficiency syndrome	0.00194	0.0246	CbGeAlD
Fospropofol—GABRG1—spinal cord—acquired immunodeficiency syndrome	0.00191	0.0241	CbGeAlD
Fospropofol—Angiopathy—Nelfinavir—acquired immunodeficiency syndrome	0.0019	0.00783	CcSEcCtD
Fospropofol—GABRB1—spinal cord—acquired immunodeficiency syndrome	0.00185	0.0234	CbGeAlD
Fospropofol—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.00184	0.00758	CcSEcCtD
Fospropofol—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.00182	0.00751	CcSEcCtD
Fospropofol—GABRB1—vagina—acquired immunodeficiency syndrome	0.00178	0.0225	CbGeAlD
Fospropofol—Paraesthesia—Amprenavir—acquired immunodeficiency syndrome	0.00169	0.00694	CcSEcCtD
Fospropofol—GABRD—nervous system—acquired immunodeficiency syndrome	0.00167	0.0211	CbGeAlD
Fospropofol—Mediastinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00164	0.00674	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00162	0.00667	CcSEcCtD
Fospropofol—GABRD—central nervous system—acquired immunodeficiency syndrome	0.00161	0.0203	CbGeAlD
Fospropofol—GABRG1—nervous system—acquired immunodeficiency syndrome	0.00161	0.0203	CbGeAlD
Fospropofol—GABRA6—nervous system—acquired immunodeficiency syndrome	0.0016	0.0202	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.00159	0.00656	CcSEcCtD
Fospropofol—Cough—Stavudine—acquired immunodeficiency syndrome	0.00159	0.00654	CcSEcCtD
Fospropofol—Cough—Abacavir—acquired immunodeficiency syndrome	0.00156	0.00644	CcSEcCtD
Fospropofol—GABRB1—nervous system—acquired immunodeficiency syndrome	0.00156	0.0197	CbGeAlD
Fospropofol—GABRA5—nervous system—acquired immunodeficiency syndrome	0.00155	0.0196	CbGeAlD
Fospropofol—GABRG1—central nervous system—acquired immunodeficiency syndrome	0.00155	0.0196	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00154	0.00636	CcSEcCtD
Fospropofol—GABRG3—brain—acquired immunodeficiency syndrome	0.00154	0.0195	CbGeAlD
Fospropofol—GABRA6—central nervous system—acquired immunodeficiency syndrome	0.00154	0.0195	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.00154	0.00634	CcSEcCtD
Fospropofol—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.00154	0.00633	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.00152	0.00624	CcSEcCtD
Fospropofol—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00151	0.00621	CcSEcCtD
Fospropofol—GABRB1—central nervous system—acquired immunodeficiency syndrome	0.0015	0.019	CbGeAlD
Fospropofol—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.00149	0.00615	CcSEcCtD
Fospropofol—GABRA5—central nervous system—acquired immunodeficiency syndrome	0.00149	0.0189	CbGeAlD
Fospropofol—Pain—Didanosine—acquired immunodeficiency syndrome	0.00146	0.00602	CcSEcCtD
Fospropofol—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00146	0.006	CcSEcCtD
Fospropofol—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00597	CcSEcCtD
Fospropofol—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00145	0.00596	CcSEcCtD
Fospropofol—GABRA3—nervous system—acquired immunodeficiency syndrome	0.00144	0.0183	CbGeAlD
Fospropofol—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.00144	0.00594	CcSEcCtD
Fospropofol—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00144	0.00593	CcSEcCtD
Fospropofol—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00144	0.00591	CcSEcCtD
Fospropofol—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00142	0.00585	CcSEcCtD
Fospropofol—GABRA4—nervous system—acquired immunodeficiency syndrome	0.00141	0.0178	CbGeAlD
Fospropofol—GABRB2—spinal cord—acquired immunodeficiency syndrome	0.0014	0.0177	CbGeAlD
Fospropofol—GABRG2—spinal cord—acquired immunodeficiency syndrome	0.0014	0.0177	CbGeAlD
Fospropofol—GABRA3—central nervous system—acquired immunodeficiency syndrome	0.00139	0.0176	CbGeAlD
Fospropofol—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.00138	0.00569	CcSEcCtD
Fospropofol—Cough—Zidovudine—acquired immunodeficiency syndrome	0.00138	0.00568	CcSEcCtD
Fospropofol—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00137	0.00563	CcSEcCtD
Fospropofol—GABRA4—central nervous system—acquired immunodeficiency syndrome	0.00136	0.0171	CbGeAlD
Fospropofol—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.00134	0.00551	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00134	0.00551	CcSEcCtD
Fospropofol—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.00133	0.00549	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00133	0.00547	CcSEcCtD
Fospropofol—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00133	0.00547	CcSEcCtD
Fospropofol—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00132	0.00542	CcSEcCtD
Fospropofol—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00131	0.00541	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00129	0.0053	CcSEcCtD
Fospropofol—Cough—Indinavir—acquired immunodeficiency syndrome	0.00128	0.00529	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00128	0.00528	CcSEcCtD
Fospropofol—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00528	CcSEcCtD
Fospropofol—GABRD—brain—acquired immunodeficiency syndrome	0.00128	0.0161	CbGeAlD
Fospropofol—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00127	0.00525	CcSEcCtD
Fospropofol—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.00524	CcSEcCtD
Fospropofol—GABRB2—lung—acquired immunodeficiency syndrome	0.00127	0.0161	CbGeAlD
Fospropofol—Pain—Stavudine—acquired immunodeficiency syndrome	0.00127	0.00523	CcSEcCtD
Fospropofol—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00127	0.00521	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00126	0.0052	CcSEcCtD
Fospropofol—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00125	0.00516	CcSEcCtD
Fospropofol—Pain—Abacavir—acquired immunodeficiency syndrome	0.00125	0.00515	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00124	0.00512	CcSEcCtD
Fospropofol—GABRA1—spinal cord—acquired immunodeficiency syndrome	0.00123	0.0156	CbGeAlD
Fospropofol—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.00508	CcSEcCtD
Fospropofol—GABRG1—brain—acquired immunodeficiency syndrome	0.00123	0.0155	CbGeAlD
Fospropofol—GABRA2—vagina—acquired immunodeficiency syndrome	0.00123	0.0155	CbGeAlD
Fospropofol—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.00505	CcSEcCtD
Fospropofol—GABRA6—brain—acquired immunodeficiency syndrome	0.00122	0.0155	CbGeAlD
Fospropofol—Cough—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00499	CcSEcCtD
Fospropofol—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00121	0.00498	CcSEcCtD
Fospropofol—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00119	0.00491	CcSEcCtD
Fospropofol—GABRB1—brain—acquired immunodeficiency syndrome	0.00119	0.0151	CbGeAlD
Fospropofol—GABRA5—brain—acquired immunodeficiency syndrome	0.00119	0.015	CbGeAlD
Fospropofol—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00118	0.00485	CcSEcCtD
Fospropofol—GABRB2—nervous system—acquired immunodeficiency syndrome	0.00118	0.0149	CbGeAlD
Fospropofol—GABRG2—nervous system—acquired immunodeficiency syndrome	0.00118	0.0149	CbGeAlD
Fospropofol—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00118	0.00484	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00118	0.00484	CcSEcCtD
Fospropofol—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00117	0.00481	CcSEcCtD
Fospropofol—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00117	0.0048	CcSEcCtD
Fospropofol—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00478	CcSEcCtD
Fospropofol—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00116	0.00477	CcSEcCtD
Fospropofol—GABRB2—central nervous system—acquired immunodeficiency syndrome	0.00113	0.0143	CbGeAlD
Fospropofol—GABRG2—central nervous system—acquired immunodeficiency syndrome	0.00113	0.0143	CbGeAlD
Fospropofol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00111	0.00459	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00111	0.00459	CcSEcCtD
Fospropofol—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00458	CcSEcCtD
Fospropofol—Pain—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00455	CcSEcCtD
Fospropofol—GABRA3—brain—acquired immunodeficiency syndrome	0.0011	0.014	CbGeAlD
Fospropofol—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.0011	0.00454	CcSEcCtD
Fospropofol—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00109	0.00448	CcSEcCtD
Fospropofol—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00109	0.00448	CcSEcCtD
Fospropofol—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00108	0.00444	CcSEcCtD
Fospropofol—GABRA4—brain—acquired immunodeficiency syndrome	0.00108	0.0136	CbGeAlD
Fospropofol—GABRA2—nervous system—acquired immunodeficiency syndrome	0.00108	0.0136	CbGeAlD
Fospropofol—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00442	CcSEcCtD
Fospropofol—GABRB3—spinal cord—acquired immunodeficiency syndrome	0.00107	0.0136	CbGeAlD
Fospropofol—Headache—Didanosine—acquired immunodeficiency syndrome	0.00107	0.00441	CcSEcCtD
Fospropofol—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.00434	CcSEcCtD
Fospropofol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00105	0.00434	CcSEcCtD
Fospropofol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00105	0.00433	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00428	CcSEcCtD
Fospropofol—GABRA1—nervous system—acquired immunodeficiency syndrome	0.00104	0.0131	CbGeAlD
Fospropofol—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00104	0.00427	CcSEcCtD
Fospropofol—GABRA2—central nervous system—acquired immunodeficiency syndrome	0.00104	0.0131	CbGeAlD
Fospropofol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00104	0.00426	CcSEcCtD
Fospropofol—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00425	CcSEcCtD
Fospropofol—Pain—Indinavir—acquired immunodeficiency syndrome	0.00103	0.00423	CcSEcCtD
Fospropofol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00102	0.00419	CcSEcCtD
Fospropofol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00102	0.00418	CcSEcCtD
Fospropofol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00418	CcSEcCtD
Fospropofol—GABRA1—central nervous system—acquired immunodeficiency syndrome	0.001	0.0127	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.001	0.00412	CcSEcCtD
Fospropofol—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000985	0.00406	CcSEcCtD
Fospropofol—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000984	0.00405	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000979	0.00403	CcSEcCtD
Fospropofol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000978	0.00403	CcSEcCtD
Fospropofol—GABRB3—lung—acquired immunodeficiency syndrome	0.000976	0.0123	CbGeAlD
Fospropofol—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000975	0.00401	CcSEcCtD
Fospropofol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000975	0.00401	CcSEcCtD
Fospropofol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00097	0.00399	CcSEcCtD
Fospropofol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000964	0.00397	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000955	0.00393	CcSEcCtD
Fospropofol—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000947	0.0039	CcSEcCtD
Fospropofol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000947	0.0039	CcSEcCtD
Fospropofol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000944	0.00389	CcSEcCtD
Fospropofol—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000938	0.00386	CcSEcCtD
Fospropofol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000938	0.00386	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000937	0.00386	CcSEcCtD
Fospropofol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000933	0.00384	CcSEcCtD
Fospropofol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000931	0.00383	CcSEcCtD
Fospropofol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00093	0.00383	CcSEcCtD
Fospropofol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000928	0.00382	CcSEcCtD
Fospropofol—Headache—Abacavir—acquired immunodeficiency syndrome	0.000917	0.00377	CcSEcCtD
Fospropofol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000914	0.00376	CcSEcCtD
Fospropofol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000913	0.00376	CcSEcCtD
Fospropofol—GABRB3—nervous system—acquired immunodeficiency syndrome	0.000904	0.0114	CbGeAlD
Fospropofol—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000904	0.00372	CcSEcCtD
Fospropofol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000903	0.00372	CcSEcCtD
Fospropofol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000901	0.00371	CcSEcCtD
Fospropofol—GABRG2—brain—acquired immunodeficiency syndrome	0.0009	0.0114	CbGeAlD
Fospropofol—GABRB2—brain—acquired immunodeficiency syndrome	0.0009	0.0114	CbGeAlD
Fospropofol—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000895	0.00369	CcSEcCtD
Fospropofol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000885	0.00364	CcSEcCtD
Fospropofol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000882	0.00363	CcSEcCtD
Fospropofol—GABRB3—central nervous system—acquired immunodeficiency syndrome	0.00087	0.011	CbGeAlD
Fospropofol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000869	0.00358	CcSEcCtD
Fospropofol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000868	0.00357	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000867	0.00357	CcSEcCtD
Fospropofol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000861	0.00355	CcSEcCtD
Fospropofol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000858	0.00353	CcSEcCtD
Fospropofol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000849	0.0035	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000834	0.00343	CcSEcCtD
Fospropofol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000828	0.00341	CcSEcCtD
Fospropofol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000826	0.0034	CcSEcCtD
Fospropofol—GABRA2—brain—acquired immunodeficiency syndrome	0.000822	0.0104	CbGeAlD
Fospropofol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000821	0.00338	CcSEcCtD
Fospropofol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000809	0.00333	CcSEcCtD
Fospropofol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000803	0.0033	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000796	0.00328	CcSEcCtD
Fospropofol—GABRA1—brain—acquired immunodeficiency syndrome	0.000795	0.01	CbGeAlD
Fospropofol—GABRA2—lymph node—acquired immunodeficiency syndrome	0.000794	0.01	CbGeAlD
Fospropofol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000788	0.00325	CcSEcCtD
Fospropofol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000768	0.00316	CcSEcCtD
Fospropofol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000767	0.00316	CcSEcCtD
Fospropofol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000763	0.00314	CcSEcCtD
Fospropofol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000752	0.0031	CcSEcCtD
Fospropofol—ALB—brain—acquired immunodeficiency syndrome	0.000743	0.00939	CbGeAlD
Fospropofol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000721	0.00297	CcSEcCtD
Fospropofol—ALB—lymph node—acquired immunodeficiency syndrome	0.000718	0.00908	CbGeAlD
Fospropofol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000713	0.00294	CcSEcCtD
Fospropofol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000711	0.00293	CcSEcCtD
Fospropofol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00071	0.00292	CcSEcCtD
Fospropofol—GABRB3—brain—acquired immunodeficiency syndrome	0.000691	0.00873	CbGeAlD
Fospropofol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00069	0.00284	CcSEcCtD
Fospropofol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000684	0.00281	CcSEcCtD
Fospropofol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00068	0.0028	CcSEcCtD
Fospropofol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000674	0.00277	CcSEcCtD
Fospropofol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000652	0.00268	CcSEcCtD
Fospropofol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000645	0.00265	CcSEcCtD
Fospropofol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000638	0.00263	CcSEcCtD
Fospropofol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000629	0.00259	CcSEcCtD
Fospropofol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000614	0.00253	CcSEcCtD
Fospropofol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000605	0.00249	CcSEcCtD
Fospropofol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000596	0.00245	CcSEcCtD
Fospropofol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000586	0.00241	CcSEcCtD
Fospropofol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000577	0.00238	CcSEcCtD
Fospropofol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000574	0.00236	CcSEcCtD
Fospropofol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000547	0.00225	CcSEcCtD
